Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gaush MeditechHKSE:02407 +0.61%67 Quick Ratio is 1.63 as of Dec. 2025, which is at its 10-year median of 1.63. GuruFocus rates HKSE:02407 with a GF Score™ of 67/100 and a GF Value™ of HK$13.39 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Gaush Meditech ranks worse than 57.21% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Gaush Meditech's quick ratio for the quarter that ended in Dec. 2025 was 1.63.
Gaush Meditech has a quick ratio of 1.63. It generally indicates good short-term financial strength.
The historical rank and industry rank for Gaush Meditech's Quick Ratio or its related term are showing as below:
HKSE:02407'
s Quick Ratio Range Over the Past 10 Years
Min: 0.4 Med: 1.63 Max: 2.12
Current: 1.63
During the past 7 years, Gaush Meditech's highest Quick Ratio was 2.12. The lowest was 0.40. And the median was 1.63.
HKSE:02407's Quick Ratio is ranked worse than 57.21% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 1.89
vs HKSE:02407: 1.63
Gaush Meditech (HKSE:02407) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Gaush Meditech Quick Ratio Related Terms
Gaush Meditech Quick Ratio Historical Data
* Premium members only.
The historical data trend for Gaush Meditech's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02407 vs ABT, SYK, MDT: Quick Ratio Comparison
For the Medical Devices subindustry, Gaush Meditech's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gaush Meditech Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Gaush Meditech's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Gaush Meditech's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gaush Meditech (HKSE:02407) has a Quick Ratio of 1.63 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Gaush Meditech and its competitors. This is near median its historical median of 1.63. Over the past decade, Gaush Meditech's Quick Ratio has ranged from 0.40 to 2.12. According to the industry distribution chart, Gaush Meditech ranks #488 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 57.2%.
Is Gaush Meditech's Quick Ratio too high?
Gaush Meditech's current Quick Ratio of 1.63 is near median its 10-year median of 1.63. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 2.12. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Gaush Meditech's value of 1.63 is 13.8% below this industry median. Based on the distribution chart, Gaush Meditech ranks #488 out of 853 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Gaush Meditech has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gaush Meditech's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Gaush Meditech ranks #488 out of 853 companies for Quick Ratio. This places Gaush Meditech in the lower half of its industry. The industry median Quick Ratio is 1.89. Gaush Meditech's value of 1.63 is 13.8% below this benchmark. Historically, Gaush Meditech's own Quick Ratio has ranged from 0.40 to 2.12 over the past decade. While the company's 10-year median is 1.63 vs. the industry median of 1.89, Gaush Meditech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gaush Meditech's current Quick Ratio of 1.63 is 13.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Gaush Meditech and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gaush Meditech's current Quick Ratio is 1.63, which is near median its own 10-year median of 1.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaush Meditech stock overvalued right now?
Based on GuruFocus' analysis, Gaush Meditech (HKSE:02407) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.39, compared to a current price of HK$4.96 — trading 63% below its estimated fair value. The current Quick Ratio is 1.63, which is near median its 10-year median of 1.63 and 13.8% below the Medical Devices & Instruments industry median of 1.89. Gaush Meditech's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Gaush Meditech (HKSE:02407), the current Quick Ratio is 1.63 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gaush Meditech (HKSE:02407) Overvalued in 2026?
Based on GuruFocus' analysis, Gaush Meditech stock appears to be undervalued.
The current stock price of HK$4.96 is trading 63% below its estimated GF Value™ of HK$13.39.
GuruFocus considers Gaush Meditech to be Possible Value Trap.
Key valuation signals for HKSE:02407:
Quick Ratio: 1.63 (near median its 10-year median of 1.63)
GF Value™: HK$13.39 vs. price of HK$4.96 (63% below fair value)
Industry Position: 13.8% below the Medical Devices & Instruments median (#488 of 853)
No single metric tells the full story. See the HKSE:02407 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gaush Meditech Ltd is a provider of a broad spectrum of manufacture and sale ophthalmic medical devices and provision of technical services. The segments of the company include Proprietary products segment that derives maximum revenue, develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; Technical services segment provides warranty services, maintenance services and other related consumables; and Others segment.
67GF Score
Get the complete analysis for HKSE:02407
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02407 has been successfully added to your 
